Vigouret JM - Search Results

1

Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host.

Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M. Meyer-Luehmann M, et al. Among authors: vigouret jm. Science. 2006 Sep 22;313(5794):1781-4. doi: 10.1126/science.1131864. Science. 2006. PMID: 16990547

2

Effects of Hydergine and its components on Lashley maze acquisition in rats.

Jaton AL, Vigouret JM. Jaton AL, et al. Among authors: vigouret jm. J Pharmacol. 1985;16 Suppl 3:51-6. J Pharmacol. 1985. PMID: 4094447 English, French.

3

Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings].

Jaton AL, Loew DM, Vigouret JM. Jaton AL, et al. Among authors: vigouret jm. Br J Pharmacol. 1977 Mar;59(3):464P-465P. Br J Pharmacol. 1977. PMID: 843708 Free PMC article. No abstract available.

4

A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].

Jaton AL, Loew DM, Vigouret JM. Jaton AL, et al. Among authors: vigouret jm. Br J Pharmacol. 1978 Mar;62(3):395P. Br J Pharmacol. 1978. PMID: 565235 Free PMC article. No abstract available.

5

Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist.

Jaton AL, Loew DM, Vigouret JM. Jaton AL, et al. Among authors: vigouret jm. Br J Pharmacol. 1976 Mar;56(3):371P. Br J Pharmacol. 1976. PMID: 944059 Free PMC article. No abstract available.

6

Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.

Loew DM, Jaton AL, Vigouret JM. Loew DM, et al. Among authors: vigouret jm. Postgrad Med J. 1976;52suppl 1:40-46. Postgrad Med J. 1976. PMID: 822407 No abstract available.

7

Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.

Karlsson G, Jaton AL, Vigouret JM. Karlsson G, et al. Among authors: vigouret jm. Neurosci Lett. 1988 May 16;88(1):69-74. doi: 10.1016/0304-3940(88)90317-5. Neurosci Lett. 1988. PMID: 2969468

8

Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine).

Loew DM, Vigouret JM, Jaton A. Loew DM, et al. Among authors: vigouret jm. Adv Biochem Psychopharmacol. 1980;23:63-74. Adv Biochem Psychopharmacol. 1980. PMID: 6104915 No abstract available.

9

[Involvement of serotoninergic mechanisms in the circling behaviour induced by apomorphine and LSD 25 in rats (author's transl)].

Jaton AL, Vigouret JM, Dravid A. Jaton AL, et al. Among authors: vigouret jm. J Physiol (Paris). 1981;77(2-3):405-11. J Physiol (Paris). 1981. PMID: 7288655 French.

10

Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.

Vigouret JM, Bürki HR, Jaton AL, Züger PE, Loew DM. Vigouret JM, et al. Pharmacology. 1978;16 Suppl 1:156-73. doi: 10.1159/000136817. Pharmacology. 1978. PMID: 565520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters